| Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate AM Aldayel, HL O'Mary, SA Valdes, X Li, SG Thakkar, BE Mustafa, Z Cui Journal of Controlled Release 283, 280-289, 2018 | 98 | 2018 |
| A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution … X Li, SG Thakkar, TB Ruwona, RO Williams III, Z Cui JOURNAL OF CONTROLLED RELEASE 209, 197-197, 2015 | 55* | 2015 |
| Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine SG Thakkar, ZN Warnken, RF Alzhrani, SA Valdes, AM Aldayel, H Xu, ... Journal of controlled release 292, 111-118, 2018 | 46 | 2018 |
| Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature Medicine 29 (6), 1379-1388, 2023 | 44 | 2023 |
| Aluminum (oxy) hydroxide nanosticks synthesized in bicontinuous reverse microemulsion have potent vaccine adjuvant activity X Li, S Hufnagel, H Xu, SA Valdes, SG Thakkar, Z Cui, H Celio ACS applied materials & interfaces 9 (27), 22893-22901, 2017 | 44 | 2017 |
| Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies N Watanabe, F Mo, R Zheng, R Ma, VC Bray, DG van Leeuwen, ... Molecular Therapy 31 (1), 24-34, 2023 | 34 | 2023 |
| The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures SG Thakkar, TB Ruwona, RO Williams III, Z Cui Human vaccines & immunotherapeutics 13 (4), 936-946, 2017 | 26 | 2017 |
| A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2′, 2′-difluorodeoxycytidine with increased solubility, stability, and antitumor activity SA Valdes, RF Alzhrani, A Rodriguez, DSP Lansakara-P, SG Thakkar, ... International journal of pharmaceutics 570, 118609, 2019 | 25 | 2019 |
| Uric acid and the vaccine adjuvant activity of aluminium (oxy) hydroxide nanoparticles SG Thakkar, H Xu, X Li, Z Cui Journal of drug targeting 26 (5-6), 474-480, 2018 | 19 | 2018 |
| Nasal aluminum (oxy) hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses H Xu, TB Ruwona, SG Thakkar, Y Chen, M Zeng, Z Cui Human vaccines & immunotherapeutics 13 (11), 2688-2694, 2017 | 17 | 2017 |
| Immunogenicity of antigen adjuvanted with AS04 and its deposition in the upper respiratory tract after intranasal administration H Xu, RF Alzhrani, ZN Warnken, SG Thakkar, M Zeng, HDC Smyth, ... Molecular Pharmaceutics 17 (9), 3259-3269, 2020 | 11 | 2020 |
| Amorphous or crystalline? A comparison of particle engineering methods and selection SG Thakkar, K Fathe, H DC Smyth Current pharmaceutical design 21 (40), 5789-5801, 2015 | 11 | 2015 |
| CD30. CAR-modified Epstein-Barr virus-specific T cells (CD30. CAR EBVSTs) provide a safe and effective off-the-shelf therapy for patients with CD30-positive lymphoma DH Quach, CA Ramos, PD Lulla, S Sharma, HR Ganesh, N Nouraee, ... Blood 140 (Supplement 1), 412-414, 2022 | 10 | 2022 |
| Methods to prepare aluminum salt-adjuvanted vaccines SG Thakkar, Z Cui Vaccine Adjuvants: Methods and Protocols, 181-199, 2017 | 10 | 2017 |
| OFF‐THE‐SHELF CD30. CAR‐MODIFIED EPSTEIN‐BARR VIRUS‐SPECIFIC T CELLS (CD30. CAR EBVSTS) PROVIDE A SAFE AND EFFECTIVE THERAPY FOR PATIENTS WITH HODGKIN LYMPHOMA (HL) CA Ramos, DH Quach, PD Lulla, RH Rouce, S Sharma, HR Ganesh, ... Hematological Oncology 41, 83-85, 2023 | 7 | 2023 |
| Safety and efficacy of off-the-shelf cd30. car-modified epstein-barr virus-specific t cells in patients with cd30-positive lymphoma DH Quach, CA Ramos, PD Lulla, S Sharma, HR Ganesh, YF Hadidi, ... Blood 138, 1763, 2021 | 7 | 2021 |
| A Bank of CD30.CAR-Modified, Epstein-Barr Virus-Specific T Cells That Lacks Host Reactivity and Resists Graft Rejection for Patients with CD30-Positive Lymphoma DH Quach, HR Ganesh, SG Thakkar, L Becerra-Dominguez, B Mehta, ... Blood, 62nd ASH Annual Meeting & Exposition 136 (1), 16, 2020 | 6 | 2020 |
| Toll-deficient Drosophila are resistant to infection by Pneumocystis spp.: additional evidence of specificity to mammalian hosts SE Evans, K Leventakos, R Ben-Ami, D You, SG Thakkar, RE Lewis, ... Virulence 1 (6), 523-525, 2010 | 6 | 2010 |
| Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed/refractory T-ALL. LQC Hill, RH Rouce, TS Smith, B Boriskie, M Srinivasan, SG Thakkar, ... Journal of Clinical Oncology 41 (16_suppl), 7002-7002, 2023 | 5 | 2023 |
| Anti-GD2 CAR NKT cells are safe and produce antitumor responses in patients with relapsed/refractory neuroblastoma A Heczey, A Courtney, N Ghatwai, S Thakkar, P Rathi, X Xu, H Ngai, ... Mol Ther 30 (4 suppl 1), 28, 2022 | 2 | 2022 |
Xinran LiPostdoc researcher, Oregon Health Science University; PhD in Pharmaceutical Science, the UniversityVerified email at utexas.edu
